| Product Code: ETC13214669 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Deep | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global Deep Brain Stimulation in Parkinson`s Disease Market was valued at USD 1.1 Billion in 2024 and is expected to reach USD 1.8 Billion by 2031, growing at a compound annual growth rate of 4.60% during the forecast period (2025-2031).
The Global Deep Brain Stimulation in Parkinson`s Disease Market is witnessing steady growth due to the rising prevalence of Parkinson`s disease worldwide. Deep brain stimulation (DBS) is a surgical treatment that involves implanting a device to deliver electrical stimulation to targeted areas of the brain, providing relief from motor symptoms such as tremors, rigidity, and bradykinesia. The market is driven by advancements in DBS technology, increasing awareness among patients and healthcare professionals, and the growing demand for minimally invasive treatment options. Key players in the market are investing in research and development to enhance the efficacy and safety of DBS devices, thereby expanding their market presence. Additionally, strategic collaborations, product launches, and regulatory approvals are contributing to market growth, making the Global Deep Brain Stimulation in Parkinson`s Disease Market a promising sector for future investment.
The Global Deep Brain Stimulation in Parkinson`s Disease Market is experiencing rapid growth due to the increasing prevalence of Parkinson`s disease worldwide. Key trends include advancements in DBS technology, such as closed-loop systems and adaptive stimulation, which offer more personalized and effective treatment options. Additionally, rising awareness about the benefits of DBS therapy among both patients and healthcare providers is driving market growth. Opportunities in the market include expanding applications of DBS beyond Parkinson`s disease, such as in treating other neurological disorders like essential tremor and epilepsy. Moreover, the increasing investments in research and development activities by key market players are expected to further propel the market growth in the coming years.
The Global Deep Brain Stimulation in Parkinson`s Disease market faces several challenges, including high costs associated with the procedure, limited access to specialized healthcare facilities offering DBS treatment, regulatory hurdles in different regions, and the need for skilled healthcare professionals to perform the surgery and manage post-operative care. Additionally, there is a lack of awareness among patients and healthcare providers about the benefits and effectiveness of DBS in treating Parkinson`s Disease, leading to underutilization of this therapy option. Market competition among device manufacturers and the ongoing research and development efforts to improve DBS technology also contribute to the challenges faced in the market. Addressing these issues will be crucial for the continued growth and adoption of Deep Brain Stimulation in Parkinson`s Disease therapy worldwide.
The global deep brain stimulation in Parkinson`s disease market is primarily driven by the increasing prevalence of Parkinson`s disease worldwide, leading to a growing demand for effective treatment options. Additionally, advancements in deep brain stimulation technology, such as improved electrode designs and surgical techniques, are enhancing the efficacy and safety of the procedure, further propelling market growth. Moreover, rising investments in research and development activities focused on exploring new applications of deep brain stimulation in Parkinson`s disease management are contributing to market expansion. Furthermore, a growing awareness among patients and healthcare professionals about the benefits of deep brain stimulation as a viable treatment option for Parkinson`s disease is also driving the market forward.
Government policies related to the Global Deep Brain Stimulation in Parkinson`s Disease Market primarily focus on regulating the safety and efficacy of the devices used in the treatment, ensuring proper training for healthcare professionals, and promoting access to this advanced therapy for patients. Regulatory bodies such as the FDA in the United States and the European Medicines Agency in the EU set standards for the approval and monitoring of deep brain stimulation devices. Additionally, government healthcare programs may provide reimbursement for the procedure to make it more accessible to patients. Policies also aim to encourage research and development in the field to improve treatment outcomes and expand the market for deep brain stimulation in Parkinson`s disease.
The Global Deep Brain Stimulation in Parkinson`s Disease Market is poised for significant growth in the coming years due to increasing prevalence of Parkinson`s disease, advancements in technology, and rising awareness about the benefits of deep brain stimulation therapy. The market is expected to witness a steady rise in demand for these devices as more healthcare providers and patients recognize the efficacy of deep brain stimulation in managing Parkinson`s symptoms. Additionally, ongoing research and development efforts aimed at improving the effectiveness and safety of these devices are likely to further drive market growth. With a growing aging population and the increasing burden of Parkinson`s disease worldwide, the Global Deep Brain Stimulation in Parkinson`s Disease Market is anticipated to expand substantially in the foreseeable future.
In the Global Deep Brain Stimulation in Parkinson`s Disease Market, North America holds a significant share due to the high prevalence of Parkinson`s disease in the region and the availability of advanced healthcare infrastructure. Europe follows closely behind, with countries like Germany, France, and the UK leading the market growth. In Asia, the market is rapidly expanding with increasing awareness about deep brain stimulation therapy and rising healthcare investments. The Middle East and Africa region are also showing growth potential, driven by improving healthcare facilities and growing adoption of innovative treatment options. Latin America is witnessing steady growth, supported by government initiatives to enhance healthcare services and rising geriatric population. Overall, the market for deep brain stimulation in Parkinson`s disease is experiencing steady growth across all regions, with varying levels of market maturity and opportunities for expansion.
Global Deep Brain Stimulation in Parkinson's Disease Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Deep Brain Stimulation in Parkinson's Disease Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Deep Brain Stimulation in Parkinson's Disease Market Revenues & Volume, 2021 & 2031F |
3.3 Global Deep Brain Stimulation in Parkinson's Disease Market - Industry Life Cycle |
3.4 Global Deep Brain Stimulation in Parkinson's Disease Market - Porter's Five Forces |
3.5 Global Deep Brain Stimulation in Parkinson's Disease Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Deep Brain Stimulation in Parkinson's Disease Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.7 Global Deep Brain Stimulation in Parkinson's Disease Market Revenues & Volume Share, By End-use, 2021 & 2031F |
4 Global Deep Brain Stimulation in Parkinson's Disease Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Deep Brain Stimulation in Parkinson's Disease Market Trends |
6 Global Deep Brain Stimulation in Parkinson's Disease Market, 2021 - 2031 |
6.1 Global Deep Brain Stimulation in Parkinson's Disease Market, Revenues & Volume, By Product, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Deep Brain Stimulation in Parkinson's Disease Market, Revenues & Volume, By Dual-Channel Deep Brain Stimulator, 2021 - 2031 |
6.1.3 Global Deep Brain Stimulation in Parkinson's Disease Market, Revenues & Volume, By Single Channel Deep Brain Stimulator, 2021 - 2031 |
6.2 Global Deep Brain Stimulation in Parkinson's Disease Market, Revenues & Volume, By End-use, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Deep Brain Stimulation in Parkinson's Disease Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.2.3 Global Deep Brain Stimulation in Parkinson's Disease Market, Revenues & Volume, By Neurology Clinics, 2021 - 2031 |
6.2.4 Global Deep Brain Stimulation in Parkinson's Disease Market, Revenues & Volume, By Ambulatory Surgical Centers, 2021 - 2031 |
6.2.5 Global Deep Brain Stimulation in Parkinson's Disease Market, Revenues & Volume, By Research Centers, 2021 - 2031 |
6.3.1 Overview & Analysis |
7 North America Deep Brain Stimulation in Parkinson's Disease Market, Overview & Analysis |
7.1 North America Deep Brain Stimulation in Parkinson's Disease Market Revenues & Volume, 2021 - 2031 |
7.2 North America Deep Brain Stimulation in Parkinson's Disease Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Deep Brain Stimulation in Parkinson's Disease Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Deep Brain Stimulation in Parkinson's Disease Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Deep Brain Stimulation in Parkinson's Disease Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Deep Brain Stimulation in Parkinson's Disease Market, Revenues & Volume, By Product, 2021 - 2031 |
7.4 North America Deep Brain Stimulation in Parkinson's Disease Market, Revenues & Volume, By End-use, 2021 - 2031 |
8 Latin America (LATAM) Deep Brain Stimulation in Parkinson's Disease Market, Overview & Analysis |
8.1 Latin America (LATAM) Deep Brain Stimulation in Parkinson's Disease Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Deep Brain Stimulation in Parkinson's Disease Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Deep Brain Stimulation in Parkinson's Disease Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Deep Brain Stimulation in Parkinson's Disease Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Deep Brain Stimulation in Parkinson's Disease Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Deep Brain Stimulation in Parkinson's Disease Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Deep Brain Stimulation in Parkinson's Disease Market, Revenues & Volume, By Product, 2021 - 2031 |
8.4 Latin America (LATAM) Deep Brain Stimulation in Parkinson's Disease Market, Revenues & Volume, By End-use, 2021 - 2031 |
9 Asia Deep Brain Stimulation in Parkinson's Disease Market, Overview & Analysis |
9.1 Asia Deep Brain Stimulation in Parkinson's Disease Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Deep Brain Stimulation in Parkinson's Disease Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Deep Brain Stimulation in Parkinson's Disease Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Deep Brain Stimulation in Parkinson's Disease Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Deep Brain Stimulation in Parkinson's Disease Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Deep Brain Stimulation in Parkinson's Disease Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Deep Brain Stimulation in Parkinson's Disease Market, Revenues & Volume, By Product, 2021 - 2031 |
9.4 Asia Deep Brain Stimulation in Parkinson's Disease Market, Revenues & Volume, By End-use, 2021 - 2031 |
10 Africa Deep Brain Stimulation in Parkinson's Disease Market, Overview & Analysis |
10.1 Africa Deep Brain Stimulation in Parkinson's Disease Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Deep Brain Stimulation in Parkinson's Disease Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Deep Brain Stimulation in Parkinson's Disease Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Deep Brain Stimulation in Parkinson's Disease Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Deep Brain Stimulation in Parkinson's Disease Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Deep Brain Stimulation in Parkinson's Disease Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Deep Brain Stimulation in Parkinson's Disease Market, Revenues & Volume, By Product, 2021 - 2031 |
10.4 Africa Deep Brain Stimulation in Parkinson's Disease Market, Revenues & Volume, By End-use, 2021 - 2031 |
11 Europe Deep Brain Stimulation in Parkinson's Disease Market, Overview & Analysis |
11.1 Europe Deep Brain Stimulation in Parkinson's Disease Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Deep Brain Stimulation in Parkinson's Disease Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Deep Brain Stimulation in Parkinson's Disease Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Deep Brain Stimulation in Parkinson's Disease Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Deep Brain Stimulation in Parkinson's Disease Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Deep Brain Stimulation in Parkinson's Disease Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Deep Brain Stimulation in Parkinson's Disease Market, Revenues & Volume, By Product, 2021 - 2031 |
11.4 Europe Deep Brain Stimulation in Parkinson's Disease Market, Revenues & Volume, By End-use, 2021 - 2031 |
12 Middle East Deep Brain Stimulation in Parkinson's Disease Market, Overview & Analysis |
12.1 Middle East Deep Brain Stimulation in Parkinson's Disease Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Deep Brain Stimulation in Parkinson's Disease Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Deep Brain Stimulation in Parkinson's Disease Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Deep Brain Stimulation in Parkinson's Disease Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Deep Brain Stimulation in Parkinson's Disease Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Deep Brain Stimulation in Parkinson's Disease Market, Revenues & Volume, By Product, 2021 - 2031 |
12.4 Middle East Deep Brain Stimulation in Parkinson's Disease Market, Revenues & Volume, By End-use, 2021 - 2031 |
13 Global Deep Brain Stimulation in Parkinson's Disease Market Key Performance Indicators |
14 Global Deep Brain Stimulation in Parkinson's Disease Market - Export/Import By Countries Assessment |
15 Global Deep Brain Stimulation in Parkinson's Disease Market - Opportunity Assessment |
15.1 Global Deep Brain Stimulation in Parkinson's Disease Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Deep Brain Stimulation in Parkinson's Disease Market Opportunity Assessment, By Product, 2021 & 2031F |
15.3 Global Deep Brain Stimulation in Parkinson's Disease Market Opportunity Assessment, By End-use, 2021 & 2031F |
16 Global Deep Brain Stimulation in Parkinson's Disease Market - Competitive Landscape |
16.1 Global Deep Brain Stimulation in Parkinson's Disease Market Revenue Share, By Companies, 2024 |
16.2 Global Deep Brain Stimulation in Parkinson's Disease Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |